|Day Low/High||11.57 / 11.85|
|52 Wk Low/High||9.30 / 17.55|
The most recent short interest data was recently released for the 08/15/2017 settlement date, and Sucampo Pharmaceuticals Inc is one of the most shorted stocks of the Russell 3000, based on 8.14 "days to cover" versus the median component at 5.20. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.
Cancer Prevention Pharmaceuticals, Inc. (CPP), a private biotech company developing novel therapeutics to prevent cancer and other diseases, announced it has received a total of $9.
Investors in Sucampo Pharmaceuticals Inc saw new options begin trading this week, for the October 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SCMP options chain for the new October 20th contracts and identified the following call contract of particular interest.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BETR, CG, DXCM, ITG, JLL, KEM, NUS, STRL, SUM, SWIR Downgrades: DVA, GHC, ISCA, QRVO, RDC, SCMP Initiations: ASPU Read on to get TheStreet Quant Ratings' detailed report:
The most recent short interest data has been released for the 06/30/2017 settlement date, which shows a 983,237 share decrease in total short interest for Sucampo Pharmaceuticals Inc , to 4,813,505, a decrease of 16.96% since 06/15/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.
Investors in Sucampo Pharmaceuticals Inc saw new options begin trading this week, for the August 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SCMP options chain for the new August 18th contracts and identified the following call contract of particular interest.
Investors considering a purchase of Sucampo Pharmaceuticals Inc stock, but tentative about paying the going market price of $9.78/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the September put at the $7.50 strike, which has a bid at the time of this writing of 50 cents.
In trading on Wednesday, shares of Sucampo Pharmaceuticals Inc crossed above their 200 day moving average of $12.44, changing hands as high as $12.75 per share. Sucampo Pharmaceuticals Inc shares are currently trading up about 12% on the day.
Sucampo Pharmaceuticals, Intellia Therapeutics and Cytokinetics were among the biotech stock movers in premarket trading on Wednesday.
Investors in Sucampo Pharmaceuticals Inc saw new options begin trading this week, for the September 15th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 234 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.